MedTrace Logo

Observation of the Result After Chondron (Autologous Chondrocytes) Treatment

NCT01056900 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 127

Last updated 2010-01-26

No results posted yet for this study

Summary

This investigator-sponsored trial attempts to evaluate the effectiveness of Chondron transplantation by tracking subjects who had the Chondron implantation to observe effectiveness.

Conditions

  • Articular Cartilage Defects of Knee

Interventions

PROCEDURE

Autologous Chondrocyte Implantation

* Test drug: Chondron (more than 12 million chondrocytes in 0.4ml, i.e. 1 vial) * Directions and dosage: Suspend the cells in the vial sufficiently, and implant them in the defective part, making sure that sufficient amounts are injected.

Sponsors & Collaborators

  • Sewon Cellontech Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Nam Yong Choi · St. Paul Hospital of Catholic Medical College

Eligibility

Min Age
15 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2009-08-31
Completion
2009-11-30

Countries

  • South Korea

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01056900 on ClinicalTrials.gov